Find the Clues to Stay Ahead of Cancer

SHERLOCK is a research study at UHN’s Princess M​argaret Cancer Centre that uses a simple blood test (“liquid biopsy”) to detect molecular residual disease (MRD)—tiny traces of cancer that may remain after treatment. By identifying MRD earlier, researchers aim to better understand cancer recurrence and explore ways to prevent it. ​​

Join SHERLOCK      Refer Your Patient​​​

Why Take Part

Get more insight into your health after treatment
This study looks for tiny fragments of cancer in your blood that may not show up on scans, helping your care team better understand what is happening in your body.

Stay one step ahead of cancer
Finding these early “clues” may help identify if cancer could come back sooner—so your doctors can monitor you more closely and consider next steps earlier.

Help guide your care and future options
Your results may help determine if you are eligible for additional clinical trials focused on preventing cancer recurrence.

Contribute to research that may benefit you and others
By taking part, you are helping researchers learn how to detect and stop cancer earlier—for you and for future patients.​​

Join SHERLOCK

If you are a UHN patient receiving cancer care at UHN, you may be eligible to take part:

1

Approach Your UHN Cancer Care Team

Ask your oncologist or a member of your UHN cancer care team about SHERLOCK. If appropriate, your care team will refer you, and a member of the study team will follow up.

2

Review and Sign a Consent Form

If you are eligible and would like to join, you will receive a consent form and can review details with the study team.

3

Provide a Blood Sample

Once enrolled, you will need to provide a blood sample. You can provide your blood sample at any UHN blood lab. Samples are collected at planned time points (often coordinated with routine visits), up to a total of 6 times over 12 months.​​

Refer Your Patient

Patient referrals must be made by a UHN cancer care team member:

1

Speak With Your Patient

Introduce the SHERLOCK study, answer questions, and confirm the patient is interested in learning more.

2

Submit A Referral

UHN staff can refer eligible patients through one of the following channels:

  • Epic: In-Basket message to the SHERLOCK pool
  • Email:SHERLOCK@uhn.ca
  • Phone: 437-757-2154 (Clinical Nurse Navigator)

Please include the following information:

  • Patient MRN
  • End date of curative-intent treatment
  • Confirmation that the patient has been briefed on SHERLOCK​


​​

Contact

Contact

For questions about the study, you can contact the SHERLOCK study team at SHERLOCK@uhn.ca or 437-757-2154.

SHERLOCK is supported by a $50 million gift from the Peter Gilgan Foundation to establish the Peter Gilgan Centre for Early Cancer Detection Research.​​

​​​​​​​​​​​​​​​​​​​

https://www.uhn.ca/PrincessMargaret/Education/Continuing_Education_Programs/Pages/continuing_education_programs.aspx
Last reviewed: 6/18/2026
Last modified: 6/19/2026 7:52 AM
Back to Top